Christopher J. Benway, Ph.D.
I am currently a computational biologist in the Sampson Lab at Boston Children's Hospital. My current research involves genome-wide association studies, statistical genetics and fine-mapping, transcriptomics, and chromatin accessibility assays.
Previously, I completed post-doctoral research at Brigham and Women's Hospital and Harvard Medical School Channing Division of Network Medicine working on genetics and functional genomics of chronic obstructive pulmonary disease (COPD). During my Ph.D. in the lab of John Iacomini at Tufts University Sackler School of Biomedical Sciences I worked on in vivo and cell-based models of calcineurin inhibitor nephrotoxicity, using transcriptomics and sequencing methods to detect in vivo miRNA:mRNA targeting. In prior work as a research technician I have largely worked on molecular and cell biology projects related to immune function, ER stress, gene therapy, and high throughput chemical biology screens.
Citations
- Total citations
- 656
- h-index
- 9
Citations by year
- 2015 5
- 2016 5
- 2017 7
- 2018 13
- 2019 18
- 2020 49
- 2021 86
- 2022 90
- 2023 96
- 2024 113
- 2025 77
- 2026 86
Google Scholar snapshot from . The 2026 count is year to date. View current metrics on Google Scholar.
Selected publications
- Chromatin Landscapes of Human Lung Cells Predict Potentially Functional COPD GWAS Variants
- GWAS Functional Variant rs2076295 Regulates Desmoplakin (DSP) Expression in Airway Epithelial Cells
- COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease
- Genome-Wide Association Study of Parametric Response Mapping in the COPDGene Study Dissects Genetic Contributions to Emphysema and Functional Small Airway Disease
- Genetic Advances in Chronic Obstructive Pulmonary Disease. Insights from COPDGene
- Defining a microRNA‐mRNA interaction map for calcineurin inhibitor induced nephrotoxicity
- MicroRNA‐494 Promotes Cyclosporine‐Induced Nephrotoxicity and Epithelial to Mesenchymal Transition by Inhibiting PTEN